These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8831097)

  • 1. Involvement of the opioid system in the anxiolytic effect of diazepam in mice.
    Tsuda M; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1996 Jun; 307(1):7-14. PubMed ID: 8831097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
    Salas SP; Roblero JS; López LF; Tachibana S; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1992 Sep; 262(3):979-86. PubMed ID: 1356155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide.
    Agmo A; Belzung C
    Neuropharmacology; 1998; 37(2):223-32. PubMed ID: 9680247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
    Fujimoto JM; Rady JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Berrendero F; Maldonado R
    Psychopharmacology (Berl); 2002 Aug; 163(1):111-7. PubMed ID: 12185408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of dynorphin A-(1-13) markedly improves cycloheximide-induced amnesia in mice.
    Ukai M; Shan-Wu X; Kobayashi T; Kameyama T
    Eur J Pharmacol; 1996 Oct; 313(1-2):11-5. PubMed ID: 8905323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist.
    Walker MJ; Lê AD; Poulos CX; Cappell H
    Brain Res; 1991 Jan; 538(2):181-6. PubMed ID: 1849435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons.
    Lai SL; Gu Y; Huang LY
    Neurosci Lett; 1998 May; 247(2-3):115-8. PubMed ID: 9655606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
    J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.
    Rodgers RJ; Augar R; Berryman N; Hansom CJ; O'Mahony ML; Palmer RM; Stevens A; Tallett AJ
    Psychopharmacology (Berl); 2006 Aug; 187(3):345-55. PubMed ID: 16802164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.